These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29282319)

  • 1. Expression of an active Gα
    Zhao X; Deng P; Iglesias-Bartolome R; Amornphimoltham P; Steffen DJ; Jin Y; Molinolo AA; de Castro LF; Ovejero D; Yuan Q; Chen Q; Han X; Bai D; Taylor SS; Yang Y; Collins MT; Gutkind JS
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E428-E437. PubMed ID: 29282319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced
    Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
    Remoli C; Michienzi S; Sacchetti B; Consiglio AD; Cersosimo S; Spica E; Robey PG; Holmbeck K; Cumano A; Boyde A; Davis G; Saggio I; Riminucci M; Bianco P
    J Bone Miner Res; 2015 Jun; 30(6):1030-43. PubMed ID: 25487351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of Gsα(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history.
    Saggio I; Remoli C; Spica E; Cersosimo S; Sacchetti B; Robey PG; Holmbeck K; Cumano A; Boyde A; Bianco P; Riminucci M
    J Bone Miner Res; 2014 Nov; 29(11):2357-68. PubMed ID: 24764158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease.
    Palmisano B; Spica E; Remoli C; Labella R; Di Filippo A; Donsante S; Bini F; Raimondo D; Marinozzi F; Boyde A; Robey P; Corsi A; Riminucci M
    J Bone Miner Res; 2019 Dec; 34(12):2171-2182. PubMed ID: 31295366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Signature and Pro-Osteoclastic Secreted Factors of Abnormal Bone-Marrow Stromal Cells in Fibrous Dysplasia.
    Michel Z; Raborn LN; Spencer T; Pan KS; Martin D; Roszko KL; Wang Y; Robey PG; Collins MT; Boyce AM; de Castro LF
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.
    de Castro LF; Burke AB; Wang HD; Tsai J; Florenzano P; Pan KS; Bhattacharyya N; Boyce AM; Gafni RI; Molinolo AA; Robey PG; Collins MT
    J Bone Miner Res; 2019 Feb; 34(2):290-294. PubMed ID: 30496606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone.
    Raimondo D; Remoli C; Astrologo L; Burla R; La Torre M; Vernì F; Tagliafico E; Corsi A; Del Giudice S; Persichetti A; Giannicola G; Robey PG; Riminucci M; Saggio I
    PLoS One; 2020; 15(1):e0227279. PubMed ID: 31999703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells.
    Riminucci M; Robey PG; Saggio I; Bianco P
    J Mol Endocrinol; 2010 Dec; 45(6):355-64. PubMed ID: 20841428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia.
    Liu Z; Yin Y; Wang Z; Xie L; Deng P; Wang D; Ji N; Zhao H; Han X; Chen Q; Chung CH; Bai D; Zhao X
    Bone; 2022 Mar; 156():116301. PubMed ID: 34952228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
    Spencer T; Pan KS; Collins MT; Boyce AM
    Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
    Pollandt K; Engels C; Kaiser E; Werner M; Delling G
    Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
    Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
    J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.
    Mariot V; Wu JY; Aydin C; Mantovani G; Mahon MJ; Linglart A; Bastepe M
    Bone; 2011 Feb; 48(2):312-20. PubMed ID: 20887824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
    Shin SJ; Lee SJ; Kim SK
    Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone.
    Fan QM; Yue B; Bian ZY; Xu WT; Tu B; Dai KR; Li G; Tang TT
    J Pathol; 2012 Sep; 228(1):45-55. PubMed ID: 22450860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNAS
    Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
    Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.
    Idowu BD; Al-Adnani M; O'Donnell P; Yu L; Odell E; Diss T; Gale RE; Flanagan AM
    Histopathology; 2007 May; 50(6):691-704. PubMed ID: 17493233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-fibrotic effects of PFKFB4-mediated glycolytic reprogramming in fibrous dysplasia.
    Lee MO; You CH; Son MY; Kim YD; Jeon H; Chang JS; Cho YS
    Biomaterials; 2016 Nov; 107():61-73. PubMed ID: 27614159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.
    Riminucci M; Liu B; Corsi A; Shenker A; Spiegel AM; Robey PG; Bianco P
    J Pathol; 1999 Jan; 187(2):249-58. PubMed ID: 10365102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.